Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea · Delayed Price · Currency is KRW 118,000
-3,100 (-2.56%)
Last updated: Jun 8, 2026, 1:38 PM KST
Daewoong Pharmaceutical Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Daewoong Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ₩207,273. The average 1-year stock price forecast is 75.65% higher than the current stock price, while the lowest is ₩200,000 (+69.49%) and the highest is ₩220,000 (+86.44%).
Price Target: ₩207,273 (+75.65%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Daewoong Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 5 |
| Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 9 | 11 |
Financial Forecast
Revenue This Year
1.50T
from 1.57T
Decreased by -4.57%
Revenue Next Year
1.63T
from 1.50T
Increased by 8.40%
EPS This Year
11.55K
from 14.45K
Decreased by -20.04%
EPS Next Year
13.57K
from 11.55K
Increased by 17.42%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5T | ||
| Avg | 1.5T | ||
| Low | 1.5T |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -4.3% | ||
| Avg | -4.6% | ||
| Low | -5.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 11,553.91 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -20.0% | ||
| Low | - |